ViVita Technologies

09/13/2022

Check out our first press release officially announcing our $1.5M NIH grant! The funding will accelerate our work to tackle cardiovascular disease using new biomaterials with blueprints for tissue and organ regeneration.

/PRNewswire/ -- ViVita Technologies, Inc. (www.vivitatechnologies.com), a life science startup developing bioactive biomaterials for tissue and organ...

09/08/2022

Back in 2019 when and InnerPlant were based out of Tim Keller's co-working office/workshop/laboratory space Inventopia, Roderick Kumimoto shared a scrappy start-up tip: pressure cookers make great alternatives to autoclaves.

Prepping to make the first batch of regenerative biomaterials in our new facilities!

08/26/2022

Meet our founders and the beginnings of ViVita Technologies!

A new approach to tissue preparation that makes heart valve replacements less likely to be rejected by the body’s immune system — potentially giving transplant patients longer, healthier lives — was the clear favorite in this year’s University of California, Davis, business plan competition ...

05/30/2018

Thrilled that we have been selected to be a Tech Futures Group client!

ViVita is a life science company developing new biomaterials for engineering off-the-shelf tissues and organs to overcome the donor shortage. Our patented, platform process makes animal tissues compatible with human patients for a broad spectrum of medical applications. ViVita’s MVP is the BARE Pa...